{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:50:00Z","timestamp":1790423400172,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R44AI055229-09A1"],"award-info":[{"award-number":["5R44AI055229-09A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2R44AI058375-06A1"],"award-info":[{"award-number":["2R44AI058375-06A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.05.008","type":"journal-article","created":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:45:47Z","timestamp":1589881547000},"page":"4592-4600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Feasibility of direct venous inoculation of the radiation-attenuated Plasmodium falciparum whole sporozoite vaccine in children and infants in Siaya, western Kenya"],"prefix":"10.1016","volume":"38","author":[{"given":"M.","family":"Oneko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.R.","family":"Cherop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"Nyang'au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.D.","family":"Odila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Akach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Hamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.M.","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kariuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.L.","family":"Nzuu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Wijayalath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.R.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.K.L.","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.F.","family":"Billingsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.L.","family":"Richie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Seder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.C.","family":"Steinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.05.008_b0005","doi-asserted-by":"crossref","unstructured":"Zhang L, Wang W, Wang S. Effect of vaccine administration modality on immunogenicity and efficacy. Expert Rev Vaccines. 2015; 14(11):1509\u201323. doi: 10.86\/14760584.2015.1081067. Epub 2015 Aug 27.","DOI":"10.1586\/14760584.2015.1081067"},{"issue":"3","key":"10.1016\/j.vaccine.2020.05.008_b0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00262-018-02294-5","article-title":"The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice","volume":"68","author":"Sultan","year":"2019","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2020.05.008_b0015","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1128\/iai.2.5.574-582.1970","article-title":"Aerosol-induced tuberculosis in subhuman primates and the course of the disease after intravenous BCG vaccination","volume":"2","author":"Barclay","year":"1970","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2020.05.008_b0020","doi-asserted-by":"crossref","unstructured":"Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, Laurens MB, et al. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science. 2011;334(6055):475\u201380. Epub 2011\/09\/08. doi: 10.1126\/science.1211548. PubMed PMID: 21903775.","DOI":"10.1126\/science.1211548"},{"issue":"6152","key":"10.1016\/j.vaccine.2020.05.008_b0025","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2020.05.008_b0030","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nm.4110","article-title":"Protection against malaria at 1 year and immune correlates following PfSPZ vaccination","volume":"22","author":"Ishizuka","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2020.05.008_b0035","doi-asserted-by":"crossref","unstructured":"Sissoko MS, Healy SA, Katile A, Omaswa F, Zaidi I, Gabriel EE, et al. Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial. Lancet Infect Dis 2017;17(5):498\u2013509. Epub 2017\/02\/16. doi: 10.1016\/S1473-3099(17)30104-4. PubMed PMID: 28216244.","DOI":"10.1016\/S1473-3099(17)30104-4"},{"issue":"2","key":"10.1016\/j.vaccine.2020.05.008_b0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4269\/ajtmh.17-1014","article-title":"Safety, immunogenicity, and protective efficacy against controlled human malaria infection of plasmodium falciparum sporozoite vaccine in Tanzanian Adults","volume":"99","author":"Jongo","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.vaccine.2020.05.008_b0045","first-page":"18","article-title":"Safety and differential antibody and T-cell responses to plasmodium falciparum sporozoite vaccine by age in tanzanian adults, adolescents, children, and infants","volume":"15","author":"Jongo","year":"2019","journal-title":"Am J Tropical Med Hygiene"},{"key":"10.1016\/j.vaccine.2020.05.008_b0050","unstructured":"National Malaria Control Programme (NMCP) KNBoSK, and ICF, 2016 I. Kenya Malaria Indicator Survey 2015; 2016."},{"key":"10.1016\/j.vaccine.2020.05.008_b0055","doi-asserted-by":"crossref","unstructured":"Steinhardt LC, Richie TL, Yego R, Akach D, Hamel MJ, Gutman JR, et al. Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya. Clin Infect Dis 2019; 26(5573993).","DOI":"10.1093\/cid\/ciz925"},{"issue":"7642","key":"10.1016\/j.vaccine.2020.05.008_b0060","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordmuller","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.05.008_b0065","doi-asserted-by":"crossref","unstructured":"Sharpe S, White A, Sarfas C, Sibley L, Gleeson F, McIntyre A, et al. Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations. Tuberculosis (Edinb). 2016;101:174\u2013190.(doi):10.1016\/j.tube.2016.09.004. Epub Oct 8.","DOI":"10.1016\/j.tube.2016.09.004"},{"key":"10.1016\/j.vaccine.2020.05.008_b0070","doi-asserted-by":"crossref","unstructured":"Schechter NL, Zempsky WT, Cohen LL, McGrath PJ, McMurtry CM, Bright NS. Pain reduction during pediatric immunizations: evidence-based review and recommendations. Pediatrics. 2007;119(5):e1184\u201398. doi: 10.542\/peds.2006-1107.","DOI":"10.1542\/peds.2006-1107"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.05.008_b0075","first-page":"S1","article-title":"Management of procedure-related pain in children and adolescents","volume":"42","author":"Paediatrics and Child Health Division TRACoP","year":"2006","journal-title":"J Paediatr Child Health"},{"issue":"18","key":"10.1016\/j.vaccine.2020.05.008_b0080","doi-asserted-by":"crossref","first-page":"E843","DOI":"10.1503\/cmaj.101720","article-title":"Reducing the pain of childhood vaccination: an evidence-based clinical practice guideline","volume":"182","author":"Taddio","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.vaccine.2020.05.008_b0085","doi-asserted-by":"crossref","unstructured":"Harrison D, Reszel J, Bueno M, Sampson M, Shah VS, Taddio A, et al. Breastfeeding for procedural pain in infants beyond the neonatal period. Cochrane Database Syst Rev. 2016; 10:CD011248. (doi):10.1002\/14651858.CD011248.pub2.","DOI":"10.1002\/14651858.CD011248.pub2"},{"key":"10.1016\/j.vaccine.2020.05.008_b0090","doi-asserted-by":"crossref","unstructured":"Richie TL, Billingsley PF, Sim BK, James ER, Chakravarty S, Epstein JE, et al. Progress with Plasmodium falciparum sporozoite (PfSPZ)-based malaria vaccines. Vaccine 2015;33(52):7452-61. Epub 2015\/11\/27. doi: 10.1016\/j.vaccine.2015.09.096. PubMed PMID: 26469720; PubMed Central PMCID: PMCPMC5077156.","DOI":"10.1016\/j.vaccine.2015.09.096"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20306149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20306149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:16:02Z","timestamp":1777536962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20306149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":18,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X20306149"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.008","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility of direct venous inoculation of the radiation-attenuated Plasmodium falciparum whole sporozoite vaccine in children and infants in Siaya, western Kenya","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}